▶ 調査レポート

世界の医療用電極市場2022-2027:成長・動向・新型コロナの影響・市場予測

• 英文タイトル:Global Medical Electrodes Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Mordor Intelligenceが調査・発行した産業分析レポートです。世界の医療用電極市場2022-2027:成長・動向・新型コロナの影響・市場予測 / Global Medical Electrodes Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) / MRC2202A021資料のイメージです。• レポートコード:MRC2202A021
• 出版社/出版日:Mordor Intelligence / 2022年1月28日
• レポート形態:英文、PDF、125ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥627,000 (USD4,750)▷ お問い合わせ
  Team User¥858,000 (USD6,500)▷ お問い合わせ
  Corporate License¥1,155,000 (USD8,750)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Mordor Intelligence社は、世界の医療用電極市場規模が年平均4.47%成長すると予想しています。本書では、医療用電極の世界市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品種類別(表面電極、針電極)分析、使用別(使い捨て医療用電極、再利用可能医療用電極)分析、種類別(心電図検査(ECG)、脳波記録(EEG)、筋電図(EMG)、脳幹聴覚誘発電位(BAEPS)、その他)分析、用途別(心臓病、神経生理、睡眠障害、術中モニタリング、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米)分析、競争状況、市場機会/将来の見通しなどを掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・市場動向
・世界の医療用電極市場規模:製品種類別(表面電極、針電極)
・世界の医療用電極市場規模:使用別(使い捨て医療用電極、再利用可能医療用電極)
・世界の医療用電極市場規模:種類別(心電図検査(ECG)、脳波記録(EEG)、筋電図(EMG)、脳幹聴覚誘発電位(BAEPS)、その他)
・世界の医療用電極市場規模:用途別(心臓病、神経生理、睡眠障害、術中モニタリング、その他)
・世界の医療用電極市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米)
・競争状況(3M、Ambu A/S、Cognionics Inc.、CONMED Corporation、Cooper Surgical Inc.、Dymedix、Koninklijke Philips NV、Medtronic Plc、Natus Medical Incorporated、Nihon Kohden Corporation)
・市場機会/将来の見通し

The Medical Electrodes Market is expected to register a CAGR of nearly 4.47% during the forecast period.

The COVID-19 pandemic has significantly impacted the medical electrodes market. Nationwide lockdowns and social distancing measures have reduced patient visits significantly. This has reduced the sales of medical electrode products. Many of the leading players in the medical electrodes market, such as Ambu, Cardinal Health, and CONMED Corporation, have registered a decline in sales for Q2 and Q3 of 2020 for their medical devices segment. According to the study published in the British Journal of Surgery, in May 2020, based on 12 weeks of peak disruption to hospital services due to COVID-19, around 28.4 million elective surgeries worldwide were expected to be canceled or postponed in 2020, this condition has affected the studied market.

The growth of the market studied can be largely attributed to the factors such as the increasing prevalence of cardiovascular and neurological diseases, increasing technological advancements and rising focus toward minimally invasive surgeries. For instance, neurological diseases are one among the major diseases, prevalent in the world. There are over 1,000 disorders of the nervous system, including cerebrovascular disease, Alzheimer’s and other dementias, migraine, epilepsy, tetanus, meningitis, Parkinson’s disease, multiple sclerosis, and poliomyelitis, among others. As per the Alzheimer Europe 2019 report, estimates that the number of people with dementia in Germany in 2018 was around 1,585,166 and this number is projected to rise to 2,748,178 in 2050. Similarly, as a percentage of the overall population with dementia will represent 3.43% in 2050 compared to 1.91% in 2018. This is likely to boost the market growth.

Moreover, rigorous investments made by the companies toward the development of efficient diagnostic and therapeutic platforms indicate the promising growth prospects of the medical electrodes market. The companies focus on growth strategies, such as new product launches, mergers and acquisitions, and portfolio expansion.For instance, in 2021, NeuroOne Medical Technologies Corporation, a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, received the US Food and Drug Administration (FDA) 510(k) clearance to market its Evo sEEG Electrode technology. Promising outcomes and increasing competition among leading medical device companies to approve and commercialize products in different areas of unmet medical needs are projected to boost the medical electrodes market.

However, the issue related to the biocompatibility of medical electrodes along with stringent regulatory guidelines, coverage, and different approval processes in various countries are significant barriers for the medical electrodes markets.

Key Market Trends

Cardiology Segment is Expected to Witness Significant Growth Rate Over the Forecast Period in the Medical Electrodes Market

The cardiology segment, by application, is expected to hold a major share in the market and is expected to do so in the upcoming future. According to the World Health Organization, an estimated 17.9 million deaths were caused by CVDs in 2019, which represented nearly 32% of all deaths across the world. Moreover, over three-quarters of deaths due to CVDs were recorded in low- and middle-income countries. Thus, the rising patient pool of CVDs is likely to propel verticle growth in the upcoming year.

Moreover, the government initiatives for spreading awareness about new strategic approaches, by supporting the research and clinical trials of the new products, are likely to boost the market’s growth. For instance, a study titled ‘Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond’ reported that the committee recommends certain impact goals, including “by 2020, to improve the cardiovascular health of all Americans by 20% while reducing deaths from cardiovascular diseases and stroke by 20%”, which require new strategic directions for the American Heart Association in its research, clinical, public health, and advocacy programs for cardiovascular health promotion and disease prevention in the next decade. This is expected to drive the market’s growth.

The standard 12-lead electrocardiogram (ECG) is one of the most commonly used medical studies in the assessment of cardiovascular diseases. It is considered as one of the most important tests for the interpretation of the cardiac rhythm, detection of myocardial ischemia and infarction, conduction system abnormalities, preexcitation, long QT syndromes, atrial abnormalities, ventricular hypertrophy, pericarditis, and other conditions. The use of standardized terminology is recommended to allow the application of ECG diagnosis across many different hospital systems and countries. As CVDs are a global health burden, studying them through ECG can help researchers understand the underlying interactions of the diseases with the body. Owing to these factors, the market is expected to grow during the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

The North American region holds the largest shares in the market studied, due to better healthcare infrastructure, effective government policies, a huge base of multinational companies, and high awareness among people, about testing and testing devices in healthcare.

The prevalence of certain chronic inflammatory disorders, such as cardiovascular diseases, diabetes, Inflammatory bowel disease (IBD), and others, is high, as compared to other chronic indications. According to the American Cancer Society, estimated that in 2020 there will be about 1.8 million new cancer cases diagnosed and approximately 606,520 cancer deaths in the United States. Medical electrodes come in the class II category, under the US Food and Drug Administration (FDA), as they are mostly used for surgical purposes.

Moreover, several market players are engaged in the implantation of various strategic initiatives including product launches. For instance, in February 2021, Stratus Medical was granted a third United States patent related to its Nimbus RF Multitined Expandable Electrode. U.S. Patent No. 10,925,664, titled METHODS FOR RADIO FREQUENCY NEUROTOMY, issued on February 23, 2021, by the United States Patent and Trademark Office. Owing to all these factors, the market studied is expected to grab the largest share in the United States.

Competitive Landscape

The Medical Electrodes Market is moderately competitive and consists of the global as well as local players. However, a major share of the market is gained by global players only. Due to the rising spread of cardiovascular and neurological diseases across the globe, companies are coming up with the novel products to cater the consumers across different geographies. 3M, Ambu A/S, Cognionics Inc., CONMED Corporation, Cooper Surgical Inc., Dymedix, Koninklijke Philips NV, Medtronic Plc, Natus Medical Incorporated and Nihon Kohden Corporation

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
レポート目次

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Cardiovascular and Neurological Diseases
4.2.2 Increasing Technological Advancements
4.2.3 Rising Focus toward Minimally Invasive Surgeries
4.3 Market Restraints
4.3.1 Biocompatibility Issues with Medical Electrodes
4.3.2 Stringent Regulatory Guidelines Associated with Medical Electrodes
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Surface Electrodes
5.1.2 Needle Electrodes
5.2 By Usability
5.2.1 Disposable Medical Electrodes
5.2.2 Reusable Medical Electrodes
5.3 By Modality Type
5.3.1 Electrocardiography (ECG)
5.3.2 Electroencephalography (EEG)
5.3.3 Electromyography (EMG)
5.3.4 Brainstem Auditory Evoked Potentials (BAEPS)
5.3.5 Other Modality Types
5.4 By Application
5.4.1 Cardiology
5.4.2 Neurophysiology
5.4.3 Sleep Disorders
5.4.4 Intraoperative Monitoring
5.4.5 Other Applications
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle-East and Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle-East and Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 3M
6.1.2 Ambu A/S
6.1.3 Cognionics Inc.
6.1.4 CONMED Corporation
6.1.5 Cooper Surgical Inc.
6.1.6 Dymedix
6.1.7 Koninklijke Philips NV
6.1.8 Medtronic Plc
6.1.9 Natus Medical Incorporated
6.1.10 Nihon Kohden Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS